Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herzig Eye Institute is a Canadian ophthalmology and vision-correction provider focused on refractive surgery, refractive cataract surgery, diagnostics, and related eye-care services. Founded in 1996, the organization operates advanced clinics in Toronto and Ottawa and markets a branded "High Definition Vision" approach that uses extensive diagnostics to match patients to the most appropriate procedure. Its commercial offerings include SMILE/SMILE Pro, LASIK, PRK, EVO ICL, refractive lens exchange, and cataract surgery, supported by ophthalmologists, optometrists, and surgical staff. The company appears to be a private, independently operated healthcare services business rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herzig Eye Institute.